程姝娟,柳景华

• 1:首都医科大学附属北京安贞医院
• 2:北京市心肺血管疾病研究所心内科28病房

摘要(Abstract)：

<正>心脏植入式电子装置,包括起搏器植入式心脏除颤器(ICD)、心脏再同步治疗除颤器(CRT-D)和心脏再同步治疗起搏器(CRT-P)术后,患者需要长期随访。以往,医生只能在程控仪上获得这些数据,不但工作负荷日趋加重,而且患者复查成本较高,会导致失访率增加而带来安全隐患。近年来,随着无线发射技术的成熟和网络技术的普及应用,远程随访和监测成为新一代器械植入术后患者新的管理模式,正逐步得到推广。国外已积累了一些经验,我国正处于起步阶段。以下对目前远程随访和监测的临床应用现状进行综述,

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 程姝娟,柳景华

参考文献(References)：

• [1]Furman S,Parker B,Escher DJ.Trans-telephone pacemaker clinic.J Thorac Cardiovasc Surg,1971,61:827-834.
• [2]Crossley GH,Chen J,Choucair W,et al.Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers.J Am Coll Cardiol,2009,54:2012-2019.
• [3]Kusumoto F,Goldschlager N.Remote monitoring of patients with implanted cardiac devices.Clin Cardiol,2010,33:10-17.
• [4]Varma N,Epstein AE,Irimpen A,et al.Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up:the Lumos-T Safely Reduces Routine Office Device Follow-up(TRUST)Trial.Circulation,2010,122:325-332.
• [5]Spencker S,Coban N,Koch L,et al.Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.Europace,2009,11:409-411.
• [6]Ricci RP,Morichelli L,Santini M.Home monitoringTM technology improves detection and clinical management of atrial fibrillation.Europace,2009,11:54-61.
• [7]Crossley GH,Boyle A,Vitense H,et al.The CONNECT(Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision)trial:The value of wireless remote monitoring with automatic clinician alerts.J Am Coll Cardiol,2011,57:1181-1189.
• [8]Glotzer TV,Hellkamp AS,Zimmerman J,et al.Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke:report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial(MOST).Circulation,2003,107:1614-1619.
• [9]Glotzer TV,Daoud EG,Wyse DG,et al.The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk:The TRENDS study.Circ Arrhythm Electrophysiol,2009,2:474-480.
• [10]Ip J,Waldo AL,Lip GY,et al.Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices:Rationale,design,and clinical characteristics of the initially enrolled cohort(The IMPACT study).Am Heart J,2009,158:364-370.e1.
• [11]Shanmugam N,Boerdlein A,Proff J,et al.Detection of atrial high-rate events by continuous Home Monitoring:clinical significance in the heart failure-cardiac resynchronization therapy population.Europace,2012,14:230-237.
• [12]Kadish A,Dyer A,Daubert JP,et al.Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation(DEFINITE)Investigators.Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.N Engl J Med,2004,350:2151-2158.
• [13]http://www.cardiostim.com/site/GB/Exhibits/2010_Trials/RAPIDRF,I484.htm
• [14]Yu CM,Wang L,Chau E,et al.Intrathoracic impedance monitoring in patients with heart failure:Correlation with fluid status and feasibility of early warning preceding hospitalization.Circulation,2005,112:841-848.
• [15]Ritzema J,Melton IC,Richards AM,et al.Direct left atrial pressure monitoring in ambulatory heart failure patients:initial experience with a new permanent implantable device.Circulation,2007,116:2952-2959.
• [16]Marinskis G,van Erven L,Bongiorni MG,et al.Practices of cardiac implantable electronic device follow-up:results of the European Heart Rhythm Association survey.Europace,2012,14:423-425.
• [17]Mabo P,Victor F,Bazin P,et al.A randomized trail of long-term remote monitoring of pacemaker recipients(The COMPAS trial).Eur Heart J,2012,33:1105-1111.
• [18]Halimi F,Cantu F.Romote monitoring for active cardiovascular immplantable electronic devices:a European survey.Europace,2010,12:1778-1780.
• [19]Movsowitz C,Mittal S.Remote patient management using implantable devices.J Interv Card Electrophysiol,2011,31:81-90.